aTyr Pharma, Inc. (ATYR)
0.2592
-0.02
(-6.86%)
USD |
NASDAQ |
Oct 08, 16:00
0.257
0.00 (0.00%)
After-Hours: 20:00
aTyr Pharma EPS Diluted (Quarterly) : -0.1051 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1051 |
| March 31, 2026 | -0.1101 |
| December 31, 2025 | -0.1425 |
| September 30, 2025 | -0.265 |
| June 30, 2025 | -0.2167 |
| March 31, 2025 | -0.172 |
| December 31, 2024 | -0.1809 |
| September 30, 2024 | -0.2277 |
| June 30, 2024 | -0.2256 |
| March 31, 2024 | -0.2344 |
| December 31, 2023 | -0.2491 |
| September 30, 2023 | -0.1959 |
| June 30, 2023 | -0.2237 |
| March 31, 2023 | -0.2852 |
| December 31, 2022 | -0.2583 |
| September 30, 2022 | -0.4621 |
| June 30, 2022 | -0.4426 |
| March 31, 2022 | -0.4369 |
| December 31, 2021 | -0.308 |
| September 30, 2021 | -0.4222 |
| June 30, 2021 | -0.6443 |
| March 31, 2021 | -0.507 |
| December 31, 2020 | -0.4664 |
| Date | Value |
|---|---|
| September 30, 2020 | -0.6839 |
| June 30, 2020 | -0.6889 |
| March 31, 2020 | 0.2545 |
| December 31, 2019 | -1.535 |
| September 30, 2019 | -1.468 |
| June 30, 2019 | -25.23 |
| March 31, 2019 | -2.540 |
| December 31, 2018 | -2.918 |
| September 30, 2018 | -3.336 |
| June 30, 2018 | -4.885 |
| March 31, 2018 | -5.012 |
| December 31, 2017 | -5.46 |
| September 30, 2017 | -6.02 |
| June 30, 2017 | -7.14 |
| March 31, 2017 | -7.84 |
| December 31, 2016 | -7.42 |
| September 30, 2016 | -8.12 |
| June 30, 2016 | -9.10 |
| March 31, 2016 | -9.52 |
| December 31, 2015 | -9.80 |
| September 30, 2015 | -6.72 |
| June 30, 2015 | -10.36 |
| March 31, 2015 | -5.438 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.31M |
| Total Expenses (Quarterly) | 10.31M |
| Enterprise Value | -19.02M |
| Earnings Yield | -240.2% |
| Normalized Earnings Yield | -240.20 |